Carin Canale-Theakston does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Cidara Therapeutics, Inc..

2021 was Carin Canale-Theakston's most active year for acquiring shares with 2 total transactions. Carin Canale-Theakston's most active month to acquire stocks was the month of May. 2026 was Carin Canale-Theakston's most active year for disposing of shares, totalling 7 transactions. Carin Canale-Theakston's most active month to dispose stocks was the month of December. 2023 saw Carin Canale-Theakston paying a total of $0.00 for 42,500 shares, this is the most they've acquired in one year. In 2026 Carin Canale-Theakston cashed out on 35,375 shares for a total of $0.00, their largest year based on trade value.